title: Oral beclomethasone therapy for recurrent small bowel allograft rejection and intestinal graft-versus-host disease.
authors.affiliation: University of Nebraska Medical Center, Omaha, Nebraska, USA.
authors.forename: D
authors.initials: D
authors.lastname: Sudan
authors.forename: W
authors.initials: W
authors.lastname: Grant
authors.forename: K
authors.initials: K
authors.lastname: Iyer
authors.forename: B
authors.initials: B
authors.lastname: Shaw
authors.forename: S
authors.initials: S
authors.lastname: Horslen
authors.forename: A
authors.initials: A
authors.lastname: Langnas
mesh_terms: D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001507:Beclomethasone / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy*; D006086:Graft vs Host Disease / Q000188:drug therapy*; D006801:Humans; D007421:Intestine, Small / Q000601:surgery*; D008297:Male; D014184:Transplantation, Homologous / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001507:Beclomethasone